Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B immunization programme: Spain

J de la Torre1

  • 1Communicable Diseases Department, Ministry of Health, Madrid, Spain.

Vaccine
|January 23, 1999
PubMed
Summary
This summary is machine-generated.

Spain shifted from selective to universal hepatitis B vaccination for adolescents in the early 1990s. This change aimed to improve disease prevention and reduce chronic hepatitis B (HB) carriers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.

HIV medicine·2023
Same author

Linezolid for infective endocarditis: A structured approach based on a national database experience.

Medicine·2021
Same author

Effect of sperm dosage transportation in stallions: Effect on sperm DNA fragmentation.

Animal reproduction science·2019
Same author

Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study.

Journal of the International Association of Providers of AIDS Care·2018
Same author

Results of an early intervention programme for patients with bacteraemia: analysis of prognostic factors and mortality.

BMC infectious diseases·2017
Same author

Equivalent seminal characteristics in human and stallion at first and second ejaculated fractions.

Andrologia·2016
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Vaccinology

Background:

  • Hepatitis B (HB) prevention in Spain historically relied on targeting high-risk groups.
  • This selective vaccination approach was insufficient to lower disease incidence or chronic carrier rates.
  • A need for a more effective strategy was identified.

Purpose of the Study:

  • To document the transition of the hepatitis B prevention strategy in Spain.
  • To highlight the implementation of universal adolescent immunization programs.
  • To assess the impact of policy changes on public health outcomes.

Main Methods:

  • Review of national and regional public health policies regarding hepatitis B vaccination.
  • Analysis of the timeline of policy implementation across autonomous regions.

Related Experiment Videos

  • Monitoring of the shift from selective to universal vaccination strategies.

    • Main Results:

    • Catalonia initiated universal adolescent hepatitis B immunization in October 1991.
    • A national recommendation for similar programs was issued in June 1992.
    • All 17 autonomous regions in Spain now implement adolescent immunization programs against HB.

    Conclusions:

    • The universal adolescent hepatitis B immunization strategy represents a significant public health advancement in Spain.
    • This policy shift is crucial for controlling hepatitis B transmission and reducing long-term health burdens.
    • Widespread adoption across autonomous regions indicates a national commitment to hepatitis B eradication.